Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Paolo Meinardi
Observed name:
Meinardi, Paolo
Institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Observed institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
ORCID:
0000-0002-2790-2296
Observed ORCID:
0000-0002-2790-2296
OpenAlex ID:
A5067446120
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab
2023
·
Domenico Mallardo
, Ester Simeone
, et al.
·
Journal of Translational Medicine
·
24
PDF
Impact of cemiplimab treatment duration on clinical outcomes in advanced cutaneous squamous cell carcinoma
2024
·
Domenico Mallardo
, Francesca Sparano
, et al.
·
Cancer Immunology Immunotherapy
·
16
Where Reflectance Confocal Microscopy Provides the Greatest Benefit for Diagnosing Skin Cancers: The Experience of the National Cancer Institute of Naples
2025
·
Marco Palla
, Gerardo Ferrara
, et al.
·
Cancers
·
4
PDF
579 Evaluation of cemiplimab treatment duration: clinical outcomes in advanced CSCC
2023
·
Domenico Mallardo
, Francesca Sparano
, et al.
·
Journal for ImmunoTherapy of Cancer
·
1
PDF
IL-6 could be a new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab
2022
·
Domenico Mallardo
, Ester Simeone
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Show more works
View as search
Works count:
11
Citation count:
45
H-index:
3
I10-index:
2
Year
Topic
Type